Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of T cell function by TCR/pMHC binding kinetics.

Leandro J Carreño1, Pablo A González, Alexis M Kalergis

  • 1Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda #340, Santiago, Chile.

Immunobiology
|February 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulatory role and therapeutic potential of thrombospondin-1 during infectious diseases and autoimmunity.

BMC biology·2026
Same author

Regulation of antiviral immunity by PD-1 during respiratory syncitial virus infection and upon vaccination.

iScience·2026
Same author

Current GMP standards for the large-scale production of monoclonal antibodies.

Bioengineering & translational medicine·2026
Same author

Carbon monoxide-producing probiotic <i>Escherichia coli</i> attenuates HSV-1 skin disease.

iScience·2026
Same author

Change in the distribution of <i>Streptococcus pneumoniae</i> serotypes causing invasive pneumococcal disease among pediatric and adult patients in Chile between 2016 and 2023.

Frontiers in microbiology·2026
Same author

The Expanding Organ Tropism of Herpes Simplex Virus Type 1.

Reviews in medical virology·2026
Same journal

WD-3 improves anti-PD-L1 therapy by remodeling the tumor immune microenvironment through gut microbiota.

Immunobiology·2026
Same journal

Interleukin 27 (IL-27) in gastrointestinal cancers: from dual roles in tumor immunity to immunotherapeutic opportunities.

Immunobiology·2026
Same journal

ST2-mediated ERK/JNK/P38/NF-κB signaling: a target of Biminkang mixture in minimal persistent inflammation of allergic rhinitis.

Immunobiology·2026
Same journal

Chronic stress promotes colorectal cancer progression by inducing M2 macrophage polarization and activating the CCL2-CCR2 axis.

Immunobiology·2026
Same journal

Spatial-cellular resolution analysis of ferroptosis-associated immune microenvironment heterogeneity in osteoarthritic cartilage.

Immunobiology·2026
Same journal

Exploring therapeutic targets for neuroinflammation in sepsis-associated encephalopathy: a combined network pharmacology and bioinformatics approach.

Immunobiology·2026
See all related articles

T cell activation relies on optimal T cell receptor (TCR) and peptide-MHC (pMHC) binding half-life, balancing pathogen response and self-reactivity. Understanding TCR/pMHC kinetics is crucial for adaptive immunity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biophysics

Background:

  • T cell recognition specificity is governed by T cell receptor (TCR) and peptide-MHC (pMHC) interactions.
  • TCR/pMHC binding kinetics, particularly half-life, are critical for T cell repertoire selection and peripheral activation.
  • Current understanding of TCR/pMHC binding kinetics in T cell activation is limited.

Purpose of the Study:

  • To review recent data on TCR/pMHC binding kinetics and T cell function.
  • To propose a new model for T cell activation regulation by TCR/pMHC binding kinetics.
  • To highlight the importance of optimal TCR/pMHC half-life for effective adaptive immunity.

Main Methods:

  • Literature review of studies on TCR/pMHC interactions and T cell activation.

Related Experiment Videos

  • Analysis of kinetic parameters, focusing on the half-life of TCR/pMHC binding.
  • Development of a conceptual model based on existing data.

    • Main Results:

    • T cell activation requires TCR/pMHC interactions above a specific half-life threshold.
    • Both insufficient and excessively long TCR/pMHC half-lives can impair T cell activation.
    • Optimal TCR/pMHC half-life is essential for efficient T cell activation and preventing self-reactivity.

    Conclusions:

    • TCR/pMHC binding kinetics, specifically half-life, are key regulators of T cell function.
    • An optimal TCR/pMHC half-life window is necessary for effective adaptive immune responses.
    • Further research into TCR/pMHC binding kinetics can refine models of T cell activation and immune regulation.